What’s The Story Behind Novavax, Inc. (NASDAQ:NVAX)

30

Novavax, Inc. (NASDAQ:NVAX) closed its last session at $1.98. The stock traded within a range of $1.89 and $2.13. The company operates in the Healthcare sector with a market capitalization of 635440. Trading volume for Novavax, Inc. was 40.8 Million in its previous trading session. Currently, Novavax, Inc. (NASDAQ:NVAX) has an average volume of 7.34 Million.

Company Profile

NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women’s health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as vehicles for the delivery of a wide variety of drugs and other therapeutic products, including certain hormones, anti-bacterial and anti-viral products and vaccine adjuvants.

Analyst Views

Novavax, Inc. (NASDAQ:NVAX) received a Buy rating from 0 analysts. 0 analysts gave its stock an Outperform rating. 2 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.

Novavax, Inc. (NASDAQ:NVAX) touched its 1-Year High price of $2.14 on 01/10/18 and its 1-Year Low price of $0.73 on 05/08/17.

EPS & Financials

Novavax, Inc. (NASDAQ:NVAX) reported its EPS in the last quarter as $-0.15/Share beating the analyst estimate of $-0.16/Share by a difference of $0.01. This showed a surprise of 6.3% in the last quarter earnings.

For the current quarter, 8 analysts are projecting a mean EPS of $-0.16/share. According to their observations and findings, the stock could provide a high EPS of $-0.14/share and a low EPS of $-0.18/share.

Analysts believe that the company has the potential to earn average revenue of $7.98 Million for the current quarter. According to their predictions high & low revenue estimates are 10.3 Million and 6 Million respectively.

Technical Analysis

By taking a look at the stock’s current statistics it can gauged that the stock candle is BULLISH with HIGH volatility. Novavax, Inc. (NASDAQ:NVAX) has a 20-Day average volume of 13.15 Million. According to today’s trading volume Novavax, Inc. is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BULLISH territory while an analysis of the last 40-Day trend shows a BULLISH signal. The 100-Day trend also shows a BULLISH trend as well.

The company currently has an insider ownership of 0.1 Percent and Institutional ownership of 38.6 Percent. The return on assets stands at -52.6%, Return on Equity currently is 452.8% and the Return on Investment value is 0%.

Novavax, Inc. (NASDAQ:NVAX) gross margin percentage stands at 0% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 50% with a 50-Day Simple Moving Average of 52.66 percent. As of today, the company has a SMA200 (200-day simple moving average) of 76.52 Percent. The Stock has YTD (year to date) performance of 59.68 percent.

The TTM operating margin for the company stands at 0%. The return on invested capital is at 0%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 0.

The company’s stock is currently moving with a +ve distance from the 200 day SMA of approximately 76.52%, and has a solid year to date (YTD) performance of 59.68% which means that the stock is constantly adding to its value from the previous fiscal year end price.